A different take: Lianjin Biotech completes a Series A funding round of over RMB 300 million, led by Sherpa Investment
Most people see this as good news. What I care more about is whether this had already been quietly priced in. It’s not uncommon for a stock to open higher and then fall on the day good news breaks.
$STAR 24h -4%. The news is just the starting point; what matters is how the money votes.
#STAR
Most people see this as good news. What I care more about is whether this had already been quietly priced in. It’s not uncommon for a stock to open higher and then fall on the day good news breaks.
$STAR 24h -4%. The news is just the starting point; what matters is how the money votes.
#STAR